Issue navigation
Volume 39, Issue 4, April 2024
EDITORIAL
Hypocalcemia: a cardiovascular risk factor coming of age?
Nephrology Dialysis Transplantation, Volume 39, Issue 4, April 2024, Pages 557–559, https://doi.org/10.1093/ndt/gfad210
The evolving role of first-tier exome sequencing in medical diagnostics
Nephrology Dialysis Transplantation, Volume 39, Issue 4, April 2024, Pages 560–563, https://doi.org/10.1093/ndt/gfad222
Beautiful and effective: what art can do for nephrologists and for our patients
Nephrology Dialysis Transplantation, Volume 39, Issue 4, April 2024, Pages 564–568, https://doi.org/10.1093/ndt/gfad228
SPECIAL REPORT
Management of adult patients with podocytopathies: an update from the ERA Immunonephrology Working Group
Nephrology Dialysis Transplantation, Volume 39, Issue 4, April 2024, Pages 569–580, https://doi.org/10.1093/ndt/gfae025
REVIEW
The global burden of antimicrobial resistance – urinary tract infections
Nephrology Dialysis Transplantation, Volume 39, Issue 4, April 2024, Pages 581–588, https://doi.org/10.1093/ndt/gfad233
Tubular toxicity of proteinuria and the progression of chronic kidney disease
Nephrology Dialysis Transplantation, Volume 39, Issue 4, April 2024, Pages 589–599, https://doi.org/10.1093/ndt/gfad215
DIAGNOSTIC STANDARD
Membranous nephropathy—diagnosis and identification of target antigens
Nephrology Dialysis Transplantation, Volume 39, Issue 4, April 2024, Pages 600–606, https://doi.org/10.1093/ndt/gfad227
ORIGINAL ARTICLE
Influence of donor sex and age on graft outcome in kidney transplantation
Nephrology Dialysis Transplantation, Volume 39, Issue 4, April 2024, Pages 607–617, https://doi.org/10.1093/ndt/gfad181
Serum phosphate is associated with increased risk of bone fragility fractures in haemodialysis patients
Nephrology Dialysis Transplantation, Volume 39, Issue 4, April 2024, Pages 618–626, https://doi.org/10.1093/ndt/gfad190
Trends in epidemiology and risk factors of opportunistic infections in kidney transplant recipients between 2004 and 2017
Nephrology Dialysis Transplantation, Volume 39, Issue 4, April 2024, Pages 627–636, https://doi.org/10.1093/ndt/gfad193
Hypocalcemia and cardiovascular mortality in cinacalcet users
Nephrology Dialysis Transplantation, Volume 39, Issue 4, April 2024, Pages 637–647, https://doi.org/10.1093/ndt/gfad213
International comparison and time trends of first kidney transplant recipient characteristics across Europe: an ERA Registry study
Nephrology Dialysis Transplantation, Volume 39, Issue 4, April 2024, Pages 648–658, https://doi.org/10.1093/ndt/gfad189
Choosing conservative care in advanced chronic kidney disease: a scoping review of patients’ perspectives
Nephrology Dialysis Transplantation, Volume 39, Issue 4, April 2024, Pages 659–668, https://doi.org/10.1093/ndt/gfad196
Haemoglobin trajectories in chronic kidney disease and risk of major adverse cardiovascular events
Nephrology Dialysis Transplantation, Volume 39, Issue 4, April 2024, Pages 669–682, https://doi.org/10.1093/ndt/gfad235
Sustained post-rituximab B-cell depletion is common in ANCA-associated vasculitis and is affected by sex and renal function
Nephrology Dialysis Transplantation, Volume 39, Issue 4, April 2024, Pages 683–693, https://doi.org/10.1093/ndt/gfad197
Accuracy of GFR estimating equations based on creatinine, cystatin C or both in routine care
Nephrology Dialysis Transplantation, Volume 39, Issue 4, April 2024, Pages 694–706, https://doi.org/10.1093/ndt/gfad219
Effects of salt and protein intake on polyuria in V2RA-treated ADPKD patients
Nephrology Dialysis Transplantation, Volume 39, Issue 4, April 2024, Pages 707–716, https://doi.org/10.1093/ndt/gfad218
RESEARCH LETTER
Examination of sex/gender disparities across the continuum of kidney transplant steps
Nephrology Dialysis Transplantation, Volume 39, Issue 4, April 2024, Pages 717–719, https://doi.org/10.1093/ndt/gfad242
Efficacy of rituximab for patients with anti-glomerular basement membrane disease
Nephrology Dialysis Transplantation, Volume 39, Issue 4, April 2024, Pages 720–723, https://doi.org/10.1093/ndt/gfad268
CORRECTION
Correction to: The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease
Nephrology Dialysis Transplantation, Volume 39, Issue 4, April 2024, Page 724, https://doi.org/10.1093/ndt/gfad252
Correction to: #5536 CIRCULATING LEVELS OF COPEPTIN, GROWTH DIFFERENTIATION FACTOR 15 (GDF15) AND INTERLEUKIN 6 (ILA-6) IN PATIENTS WITH ADVANCED KIDNEY DISEASE
Nephrology Dialysis Transplantation, Volume 39, Issue 4, April 2024, Page 725, https://doi.org/10.1093/ndt/gfad255
Correction to: Sarcopenia and mild kidney dysfunction and risk of all-cause and cause-specific mortality in older adults
Nephrology Dialysis Transplantation, Volume 39, Issue 4, April 2024, Page 726, https://doi.org/10.1093/ndt/gfad264
